Landsberg Bennett & Dubbaneh LLC Trims Position in Teladoc Health Inc (NYSE:TDOC)

Landsberg Bennett & Dubbaneh LLC lessened its stake in shares of Teladoc Health Inc (NYSE:TDOC) by 0.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 36,274 shares of the health services provider’s stock after selling 234 shares during the period. Landsberg Bennett & Dubbaneh LLC owned 0.05% of Teladoc Health worth $2,413,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. CENTRAL TRUST Co raised its holdings in shares of Teladoc Health by 82.6% during the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock worth $27,000 after acquiring an additional 171 shares during the period. Meridian Wealth Management LLC purchased a new stake in Teladoc Health in the 2nd quarter valued at about $27,000. Westside Investment Management Inc. purchased a new stake in Teladoc Health in the 2nd quarter valued at about $26,000. Cornerstone Advisors Inc. raised its holdings in Teladoc Health by 187.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 465 shares of the health services provider’s stock valued at $31,000 after buying an additional 303 shares during the period. Finally, Reilly Financial Advisors LLC purchased a new stake in Teladoc Health in the 2nd quarter valued at about $33,000.

In other Teladoc Health news, SVP Andrew Turitz sold 9,158 shares of the business’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $62.27, for a total transaction of $570,268.66. Following the sale, the senior vice president now directly owns 6,827 shares in the company, valued at $425,117.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Lewis Levy sold 1,350 shares of the business’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $67.79, for a total value of $91,516.50. Following the transaction, the insider now directly owns 5,230 shares of the company’s stock, valued at $354,541.70. The disclosure for this sale can be found here. Insiders have sold 67,036 shares of company stock worth $4,622,050 over the last quarter. Insiders own 3.95% of the company’s stock.



Several analysts recently issued reports on the stock. Craig Hallum boosted their price objective on shares of Teladoc Health from $70.00 to $80.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Oppenheimer set a $83.00 price objective on shares of Teladoc Health and gave the company a “buy” rating in a report on Friday, September 6th. JPMorgan Chase & Co. boosted their price objective on shares of Teladoc Health from $82.00 to $83.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Jefferies Financial Group restated a “buy” rating and issued a $95.00 price objective on shares of Teladoc Health in a report on Tuesday, July 2nd. Finally, Svb Leerink restated an “outperform” rating on shares of Teladoc Health in a report on Thursday, August 1st. Two research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $79.14.

NYSE:TDOC traded down $0.85 on Friday, reaching $67.16. 88,139 shares of the company’s stock were exchanged, compared to its average volume of 1,579,352. The company has a quick ratio of 7.56, a current ratio of 7.56 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $4.90 billion, a price-to-earnings ratio of -46.84 and a beta of 1.37. The business has a fifty day moving average of $64.34 and a 200-day moving average of $62.02. Teladoc Health Inc has a 52-week low of $42.08 and a 52-week high of $75.93.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.40) by ($0.01). The business had revenue of $130.30 million for the quarter, compared to analysts’ expectations of $129.54 million. Teladoc Health had a negative return on equity of 10.64% and a negative net margin of 21.85%. The firm’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter last year, the company earned ($0.40) earnings per share. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.56 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: How is the LIBOR rate calculated?

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.